ArticleEMBO molecular medicine2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.

Helena Sorger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.